Cencora (NYSE:COR) versus Aeon Global Health (OTCMKTS:AGHC) Critical Comparison

Cencora (NYSE:COR) and Aeon Global Health (OTCMKTS:AGHC) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Profitability

This table compares Cencora and Aeon Global Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cencora	0.78%	135.20%	4.20%
Aeon Global Health	N/A	N/A	N/A

Valuation & Earnings

This table compares Cencora and Aeon Global Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33 billion	0.16	$1.55 billion	$13.04	20.85
Aeon Global Health	N/A	N/A	N/A	N/A	N/A

Cencora has higher revenue and earnings than Aeon Global Health.

Analyst Recommendations

This is a breakdown of current ratings for Cencora and Aeon Global Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0	3	12	0	2.80
Aeon Global Health	0	0	0	0	0.00

Cencora presently has a consensus target price of $380.25, indicating a potential upside of 39.88%. Given Cencora’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Cencora is more favorable than Aeon Global Health.

Institutional and Insider Ownership

97.5% of Cencora shares are owned by institutional investors. 0.4% of Cencora shares are owned by company insiders. Comparatively, 11.5% of Aeon Global Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Cencora beats Aeon Global Health on 8 of the 9 factors compared between the two stocks.

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

About Aeon Global Health

AEON Global Health Corp. is a growth oriented provider of personalized, actionable medical informatics, and telemedicine. It offers a comprehensive menu of diagnostic and laboratory developed assays, as well as interpretive data for a range of inherited conditions. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.